Latest filings (excl ownership)
15-12B
Securities registration termination
26 Jul 21
EFFECT
Notice of effectiveness
19 Jul 21
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Jul 21
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Jul 21
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Jul 21
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Jul 21
POSASR
Automatic shelf registration (post-effective amendment)
15 Jul 21
POSASR
Automatic shelf registration (post-effective amendment)
15 Jul 21
POS AM
Prospectus update (post-effective amendment)
15 Jul 21
8-K
Completion of Acquisition or Disposition of Assets
15 Jul 21
25-NSE
Exchange delisting
15 Jul 21
SC TO-T/A
Third party tender offer statement (amended)
15 Jul 21
SC 14D9/A
Tender offer solicitation (amended)
15 Jul 21
SC TO-T/A
Third party tender offer statement (amended)
6 Jul 21
SC 14D9/A
Tender offer solicitation (amended)
6 Jul 21
SC TO-T/A
Third party tender offer statement (amended)
1 Jul 21
SC 14D9/A
Tender offer solicitation (amended)
1 Jul 21
SC TO-T/A
Third party tender offer statement (amended)
1 Jul 21
SC 14D9/A
Tender offer solicitation (amended)
1 Jul 21
SC 14D9
Tender offer solicitation
16 Jun 21
SC TO-T
Third party tender offer statement
16 Jun 21
SC14D9C
Written communication relating to third party tender offer
4 Jun 21
SC TO-C
Information about tender offer
2 Jun 21
8-K
Submission of Matters to a Vote of Security Holders
2 Jun 21
8-K
MorphoSys to Acquire Constellation Pharmaceuticals
2 Jun 21
SC14D9C
Written communication relating to third party tender offer
2 Jun 21
10-Q
2021 Q1
Quarterly report
10 May 21
DEFA14A
Additional proxy soliciting materials
23 Apr 21
DEF 14A
Definitive proxy
23 Apr 21
CT ORDER
Confidential treatment order
29 Mar 21
S-8
Registration of securities for employees
24 Feb 21
10-K
2020 FY
Annual report
24 Feb 21
8-K
Other Events
7 Dec 20
8-K
Entry into a Material Definitive Agreement
18 Nov 20
8-K
Termination of a Material Definitive Agreement
9 Nov 20
10-Q
2020 Q3
Quarterly report
29 Oct 20
10-Q
2020 Q2
Quarterly report
5 Aug 20
8-K
Constellation Pharmaceuticals Announces Pricing of Public Offering of Common Stock
17 Jun 20
424B5
Prospectus supplement for primary offering
17 Jun 20
8-K
Other Events
15 Jun 20
Latest ownership filings
4/A
Steven L. Hoerter
23 Jul 21
4
Jeffrey Humphrey
19 Jul 21
4
Karen Valentine
19 Jul 21
4
Elizabeth Trehu
19 Jul 21
4
Patrick Trojer
19 Jul 21
4
Emma Reeve
19 Jul 21
4
Jigar Raythatha
19 Jul 21
4
Steven L. Hoerter
19 Jul 21
4
MARK A GOLDSMITH
19 Jul 21
4
Scott Braunstein
19 Jul 21
4
James E Audia
19 Jul 21
4
Richard S Levy
19 Jul 21
4
Richard S Levy
4 Jun 21
4
Scott Braunstein
4 Jun 21
4
MARK A GOLDSMITH
4 Jun 21
4
Elizabeth Trehu
4 Jun 21
4
Steven L. Hoerter
4 Jun 21
4
James E Audia
4 Jun 21
4
MARK A GOLDSMITH
8 Mar 21
5
MARK A GOLDSMITH
8 Mar 21
4
Emma Reeve
23 Feb 21
4
Peter Svennilson
19 Feb 21
4
Tim Kutzkey
19 Feb 21
4
Emma Reeve
19 Feb 21
4
Jeffrey Humphrey
18 Feb 21
4
Jigar Raythatha
18 Feb 21
4
Karen Valentine
18 Feb 21
4
Patrick Trojer
18 Feb 21
4
Emma Reeve
18 Feb 21
SC 13G/A
Bain Capital Life Sciences Fund, L.P.
16 Feb 21
SC 13G/A
Cormorant Asset Management, LP
16 Feb 21
SC 13G/A
GREAT POINT PARTNERS LLC
16 Feb 21
SC 13G/A
COLUMN GROUP L P
16 Feb 21
SC 13G/A
THIRD ROCK VENTURES LP
16 Feb 21
SC 13G/A
Avoro Capital Advisors LLC
12 Feb 21
SC 13G
WELLINGTON MANAGEMENT GROUP LLP
4 Feb 21
SC 13G
BlackRock Inc.
2 Feb 21
SC 13G
REGENTS OF THE UNIVERSITY OF CALIFORNIA
1 Feb 21
5
MARK A GOLDSMITH
26 Jan 21
4
Karen Valentine
20 Jan 21